Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures

References

• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer2015136E359E38625220842
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKMJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• StanSDSinghSVBrandREChemoprevention strategies for pancreatic cancerNat Rev Gastroenterol Hepatol2010734735620440279
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin20166673026742998
   PubMed Web of Science ®Google Scholar
• IovannaJMallmannMCGoncalvesATurriniODagornJCCurrent knowledge on pancreatic cancerFront Oncol20122622655256
   PubMedGoogle Scholar
• HidalgoMPancreatic cancerN Engl J Med20103621605161720427809
   PubMed Web of Science ®Google Scholar
• FlossmannERothwellPMEffect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesLancet20073691603161317499602
   PubMed Web of Science ®Google Scholar
• BraskyTMLiuJWhiteENon-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women’s Health InitiativeInt J Cancer20141351869188324599876
   PubMed Web of Science ®Google Scholar
• BradleyMCHughesCMCantwellMMNapolitanoGMurrayLJNon-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control studyBr J Cancer20101021415142120372155
   PubMed Web of Science ®Google Scholar
• RayburnEREzellSJZhangRAnti-inflammatory agents for cancer therapyMol Cell Pharmacol20091294320333321
   PubMedGoogle Scholar
• BackhusLMPetasisNAUddinJDimethyl celecoxib as a novel non-cyclooxygenase 2 therapy in the treatment of non-small cell lung cancerJ Thorac Cardiovasc Surg20051301406141216256796
   PubMed Web of Science ®Google Scholar
• SobolewskiCRhimJLegrandN2,5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cellsJ Pharmacol Exp Ther201535530832826330537
   PubMed Web of Science ®Google Scholar
• KardoshASorianoNLiuYTMultitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxibBlood20051064330433816123214
   PubMed Web of Science ®Google Scholar
• LeeKPiazzaAGThe interaction between the Wnt/beta-catenin signaling cascade and PKG activation in cancerJ Biomed Res20173118919628808213
   PubMed Web of Science ®Google Scholar
• SohJWKaziJULiHThompsonWJWeinsteinIBCelecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase GMol Carcinog20084751952518163459
   PubMed Web of Science ®Google Scholar
• WickMHurteauGDessevCPeroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growthMol Pharmacol2002621207121412391285
   PubMed Web of Science ®Google Scholar
• AricoSPattingreSBauvyCCelecoxib induces apoptosis by inhibiting 3;:-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell lineJ Biol Chem2002277276132762112000750
   PubMed Web of Science ®Google Scholar
• PanMRHungWCNonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcriptionJ Biol Chem2002277327753278012087091
   PubMed Web of Science ®Google Scholar
• FerrariVValcamonicoFAmorosoVGemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trialCancer Chemother Pharmacol20065718519016151811
   PubMed Web of Science ®Google Scholar
• WarnerTDGiulianoFVojnovicBukasaAMitchellJAVaneJRNonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysisProc Natl Acad Sci USA1999967563756810377455
   PubMed Web of Science ®Google Scholar
• GierseJKValdecoxib: assessment of cyclooxygenase-2 potency and selectivityJ Pharmacol Exp Ther20043121206121215494548
   PubMed Web of Science ®Google Scholar
• OuYQZhuWLiYAspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicityActa Pharmacol Sin201031738019966835
   PubMed Web of Science ®Google Scholar
• MarnettLJKalgutkarASStructural diversity of selective COX-2 inhibitorsPairetMvan RynJCOX-2 inhibitorsBostonBirkhauser-Verlag20041540
   Google Scholar
• AtukoralaIHunterDJValdecoxib: the rise and fall of a COX-2 inhibitorExpert Opin Pharmacother2013141077108623517091
   PubMed Web of Science ®Google Scholar
• BarnettJChowJIvesDPurification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus systemBiochim Biophys Acta199412091301397947975
   PubMedGoogle Scholar
• AntoniDBurckelHJossetENoelGThree-dimensional cell culture: a breakthrough in vivoInt J Mol Sci2015165517552725768338
   PubMed Web of Science ®Google Scholar
• WareMJColbertKKeshishianVGeneration of homogenous three-dimensional pancreatic cancer cell spheroids using an improved hanging drop techniqueTissue Eng Part C Methods20162231232126830354
   PubMed Web of Science ®Google Scholar
• YeonSENo daYLeeSHApplication of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance modelPLoS One20138e7334524039920
   PubMed Web of Science ®Google Scholar
• LongatiPJiaXEimerJ3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testingBMC Cancer2013139523446043
   PubMed Web of Science ®Google Scholar
• LiHFanXHoughtonJTumor microenvironment: the role of the tumor stroma in cancerJ Cell Biochem200710180581517226777
   PubMed Web of Science ®Google Scholar
• CuiJGuoYHZhangHYCyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroidsOnco Targets Ther2014735336324591842
   PubMed Web of Science ®Google Scholar
• SarkarFHAdsuleSLiYPadhyeSBack to the future: COX-2 inhibitors for chemoprevention and cancer therapyMini Rev Med Chem2007759960817584158
   PubMed Web of Science ®Google Scholar
• DingNCuiXXGaoZA triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumorsInt J Oncol2014442139214524647860
   PubMed Web of Science ®Google Scholar
• XuXTHuWTZhouJYTuYCelecoxib enhances the radiosensitivity of HCT116 cells in a COX-2 independent manner by up-regulating BCCIPAm J Transl Res201791088110028386336
   PubMed Web of Science ®Google Scholar